--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Deovita" developer_entity: "Centro de Diagnostico Costa e Cavalcante Ltda" bundle_id: "com.deovita.app" app_store_id: "1545985928" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-05-25" report_date: "2026-08-31" last_verified: "2026-08-31T00:00:00.000Z" report_version: "27.0.3" total_reviews: 1 overall_rating: 5 confidence: "low" confidence_score: 0.2 data_age_days: 76 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "families", "individuals", "brazil"] canonical_url: "https://marlvel.ai/apps/deovita" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Deovita Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 5 > **TL;DR:** Deovita is a medical app by Centro de Diagnostico Costa e Cavalcante Ltda, rated 5/5 by 1 users, available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Deovita is a medical app by Centro de Diagnostico Costa e Cavalcante Ltda. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 5/5 (1 review) | | **Category** | Medical | | **Developer** | Centro de Diagnostico Costa e Cavalcante Ltda | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Low (0.2/1.0) | | **Data Age** | 76d | ## Metadata & Market Performance - **Publisher:** Centro de Diagnostico Costa e Cavalcante Ltda - **Category:** Medical - **Target Audience:** Families and individuals in Brazil seeking affordable, on-demand access to medical specialists and veterinary advice. - **Platforms:** iOS & Android - **Version Reviewed:** 27.0.3 - **Report Date:** 2026-08-31 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.2/1.0) - **App Store ID (iOS):** 1545985928 - **Bundle ID:** com.deovita.app - **Google Play ID:** com.deovita.app - **Performance Trend:** Stable - **Data Window:** Analysis based on signals collected up to 2026-08-31 - **Short Description:** A smart way to take care of your health ## Executive Snapshot **What it is:** Deovita is a subscription-based telemedicine app for Brazilian users, providing 24/7 access to medical specialists and veterinary care via video consultation. **Why users hire it:** The platform removes the financial friction of private medical consultations for families by providing a flat-rate monthly subscription model. ## App DNA (Features & Intent) - **[Standard] Telemedicine 24/7:** Unlimited video consultations with general practitioners and pediatricians, serving as the primary subscription gate. * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Telepet:** Virtual veterinary consultations for dogs and cats, reducing churn by bundling pet care with human health services. - **[Differentiator] Discount Network:** Up to 80% off private consultations and pharmacy discounts, incentivizing long-term retention. ## Market Position {#market-position} Deovita currently ranks #116 in the Brazilian Medical category. The lack of recent major feature updates suggests a focus on maintaining existing infrastructure rather than aggressive market share expansion. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Individual plan at R$ 19.90/month, Family plan (up to 4 dependents) at R$ 29.90/month - **Analysis:** Subscription model anchored at R$ 19.90/month with a 12-month loyalty commitment and additional copayments for specific consultations. ## SWOT Analysis {#swot} **Core Strengths:** - Telepet bundle creates household-level retention - Pharmacy discount network increases subscription utility **Growth Levers:** - Untapped market for affordable family health plans ## Recent Changes (v2 → v3) {#recent-changes} Deovita has refined its market positioning to emphasize specific pharmacy discount metrics and family-plan affordability, while updating its SWOT analysis to acknowledge increased competitive vulnerability. The core product development remains stagnant, with no new features or updates reported. **Overall trend**: Stable **Compared at**: 2026-08-31 ### High-impact changes - **[Added] Expanded Threat and Weakness Profile** (swot) ### Medium-impact changes - **[Improved] Increased Pricing and Discount Transparency** (pricing) - **[Shifted] Refined Value Proposition** (positioning) ## What's New - **Latest (v38.5.28, 5 months ago):** Implemented deep linking functionality. ## App Momentum (Maintenance) {#momentum} - Ships minor technical adjustments quarterly. - Last major release over five months ago. > **Cadence:** 2 total versions · 0 majors in last 6 months · 97 days since last update · 60 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Deovita is a medical app. It holds a 5/5 rating from 1 review. > **Bottom Line:** Deovita maintains a stable position by serving the underserved Brazilian market with affordable, bundled health access. The PM should prioritize feature expansion over maintenance to defend this niche against potential new entrants, as the current lack of development leaves the platform vulnerable. **Best for:** Families and individuals in Brazil seeking affordable, on-demand access to medical specialists and veterinary advice. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship a referral program because the current user base lacks growth loops → increase organic install velocity ### Outlook: Stable The Brazilian telemedicine market is consolidating, and Deovita's focus on low-cost family bundles provides a defensible position against premium insurers. However, the lack of recent feature updates leaves the platform exposed to more agile competitors who may introduce better-integrated social or referral features. - ⚪ The maintenance-only release cadence suggests a focus on operational stability rather than rapid feature expansion, which limits the potential for new user acquisition. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 5/5 | | Total Reviews | 1 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Stable | | Outlook | Stable | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Deovita** (this app) | 5/5 | N/A | Centro de Diagnostico Costa e Cavalcante Ltda | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Centro de Diagnostico Costa e Cavalcante Ltda - **Website:** [https://deovita.com.br](https://deovita.com.br) - **Social:** [Instagram](https://www.instagram.com/deovitasaude) · [Facebook](https://www.facebook.com/DeoVitaSaude) · [YouTube](https://www.youtube.com/watch) ## Data Sources & Links - **App Store ID:** 1545985928 - **Google Play ID:** com.deovita.app - **Dev Site:** [Official Website](https://deovita.com.br) - **Sources:** Developer website content, App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.2/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 76 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/deovita) Data licensed for AI Agent attribution under CC-BY-NC 4.0.